Defiance ETFs’s Hims & Hers Health HIMS Stock Holding History

Defiance ETFs’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,424,258	Closed	-$154M	–	399
2026 Q1	$154M	Buy	+7,424,258	New	+$175M	2.21%	8

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Defiance ETFs's HIMS Position: Q2 2026 in Review

Defiance ETFs sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 7,424,258 shares — an estimated $154M sold.

Defiance ETFs first reported a position in HIMS in Q1 2026 and held it in 1 quarter. The position peaked at $154M in Q1 2026. 505 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Defiance ETFs reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
Defiance ETFs sold 7,424,258 Hims & Hers Health shares in Q2 2026, an estimated $154M.
Defiance ETFs first reported a position in Hims & Hers Health in Q1 2026 and held it in 1 quarter.
Defiance ETFs's Hims & Hers Health position peaked at $154M in Q1 2026.
505 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.